› 2f2c

X-ray diffraction
2.8Å resolution

X-ray structure of human CDK6-Vcyclinwith the inhibitor aminopurvalanol

Released:
DOI: 10.2210/pdb2f2c/pdb
PDB entry 2f2c coloured by chain, front view.
PDB entry 2f2c coloured by chain, side view.
PDB entry 2f2c coloured by chain, top view.
Source organisms:
Primary publication:
Toward understanding the structural basis of cyclin-dependent kinase 6 specific inhibition.
Lu H, Schulze-Gahmen U
J Med Chem 49 3826-31 (2006)
PMID: 16789739

Function and Biology Details

Reaction catalysed: 
ATP + a protein = ADP + a phosphoprotein
Biochemical function:
Biological process:
Cellular component:
Sequence domains:
Structure domains:

Structure analysis Details

Assembly composition:
hetero dimer (preferred)
Assembly name:
PDBe Complex ID:
PDB-CPX-169440 (preferred)
Entry contents:
2 distinct polypeptide molecules
Macromolecules (2 distinct):
Cyclin homolog Chain: A
Molecule details ›
Chain: A
Length: 254 amino acids
Theoretical weight: 28.67 KDa
Source organism: Herpesvirus saimiri (strain 11)
Expression system: Spodoptera frugiperda
UniProt:
  • Canonical: Q01043 (Residues: 1-254; Coverage: 100%)
Gene names: 72, ECLF2
Sequence domains:
Structure domains: Cyclin-like
Cyclin-dependent kinase 6 Chain: B
Molecule details ›
Chain: B
Length: 308 amino acids
Theoretical weight: 35.07 KDa
Source organism: Homo sapiens
Expression system: Spodoptera frugiperda
UniProt:
  • Canonical: Q00534 (Residues: 1-308; Coverage: 95%)
Gene names: CDK6, CDKN6
Sequence domains: Protein kinase domain
Structure domains:

Ligands and Environments

3 bound ligands:
Ligand SO4 1 x SO4
Ligand AP9 1 x AP9
Ligand DMS 1 x DMS
No modified residues

Experiments and Validation Details

Entry percentile scores
X-ray source: ALS BEAMLINE 5.0.1
Spacegroup: P6522
Unit cell:
a: 71.517Å b: 71.517Å c: 449.297Å
α: 90° β: 90° γ: 120°
R-values:
R R work R free
0.241 0.238 0.301
Expression system: Spodoptera frugiperda

Quick links

Citations

13 review citations

FDA-approved small-molecule kinase inhibitors.
Wu et al. (2015)
12 more

7 mentions without citation

Targeting CDK6 in cancer: State of the art and new insights.
Tadesse et al. (2015)
6 more